Cargando…
Immune Checkpoint Inhibitor Associated Myocarditis and Cardiomyopathy: A Translational Review
SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) are novel cancer therapeutics that address the immune system to attack malignancies. While this therapy has significantly improved the outcome of a variety of tumor patients, it has been associated with a new class of side effects, so-called immune...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045178/ https://www.ncbi.nlm.nih.gov/pubmed/36979163 http://dx.doi.org/10.3390/biology12030472 |